• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重症急性慢性阻塞性肺疾病加重期ICU患者生命维持治疗的 withhold 与死亡率:一项法国回顾性队列研究

Withholding of Life-Sustaining Treatment and Mortality in ICU Patients with Severe Acute COPD Exacerbations: A Retrospective French Cohort.

作者信息

Puechoultres Pauline, Jamme Matthieu, Abi-Abdallah Georges, Diop Sylvain, Legriel Stéphane, Ferré Alexis

机构信息

Intensive Care Unit, Versailles Hospital, Le Chesnay, France.

Intensive Care Unit, West Parisian Private Hospital, Ramsay-Générale de Santé, Trappes, France.

出版信息

Int J Chron Obstruct Pulmon Dis. 2025 Jun 18;20:1995-2009. doi: 10.2147/COPD.S502019. eCollection 2025.

DOI:10.2147/COPD.S502019
PMID:40551759
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12183566/
Abstract

BACKGROUND

Data on withholding life-support (WLS) decisions during acute exacerbations of chronic obstructive pulmonary disease (COPD) in the intensive care unit (ICU) are scarce. This study aimed to identify factors associated with these decisions and their impact on mortality.

METHODS

We conducted a monocentric retrospective cohort study on all patients admitted to our ICU between 2015 and 2021 for a severe acute exacerbation of COPD. Logistic multivariable regression analysis was performed.

RESULTS

We included 463 patients of whom 128 (27.6%) had a decision of withholding of care. The 3-months mortality was 49.2% and 4.8% in the WLS group and in the no WLS group, respectively. Forty-eight patients (10.4%) had advanced healthcare directives. In multivariable analysis, factors associated with a decision of WLS were higher age (odds ratio [+10 years] = 1.93, < 0.001), immunodeficiency (OR = 3.07, < 0.001), higher Performance Status (PS) score (OR [+1 point] = 2.10, < 0.001), long-term oxygen therapy (OR = 4.11, < 0.001) and shock after ICU admission (OR = 2.43, = 0.01). In multivariate analysis, factors significantly associated with 3-month mortality included decision of WLS during ICU (OR = 22.98, < 0.001) and invasive mechanical ventilation (OR = 2.72, p < 0.001).

CONCLUSION

Approximately 30% of COPD patients underwent a decision to withhold life-sustaining treatment. Higher age, immunosuppression, increased PS score, and long-term oxygen therapy were significantly associated with this decision. Nearly half of the patients died within three months following a withholding of care decision.

摘要

背景

关于重症监护病房(ICU)中慢性阻塞性肺疾病(COPD)急性加重期停止维持生命治疗(WLS)决策的数据很少。本研究旨在确定与这些决策相关的因素及其对死亡率的影响。

方法

我们对2015年至2021年间因COPD严重急性加重入住我院ICU的所有患者进行了单中心回顾性队列研究。进行了多变量逻辑回归分析。

结果

我们纳入了463例患者,其中128例(27.6%)有停止治疗的决策。WLS组和非WLS组的3个月死亡率分别为49.2%和4.8%。48例患者(10.4%)有预先医疗指示。在多变量分析中,与WLS决策相关的因素包括年龄较大(优势比[每增加10岁]=1.93,<0.001)、免疫缺陷(OR=3.07,<0.001)、较高的体能状态(PS)评分(OR[每增加1分]=2.10,<0.001)、长期氧疗(OR=4.11,<0.001)和入住ICU后休克(OR=2.43,=0.01)。在多变量分析中,与3个月死亡率显著相关的因素包括ICU期间的WLS决策(OR=22.98,<0.001)和有创机械通气(OR=2.72,p<0.001)。

结论

约30%的COPD患者接受了停止维持生命治疗的决策。年龄较大、免疫抑制、PS评分增加和长期氧疗与该决策显著相关。近一半的患者在停止治疗决策后的三个月内死亡。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67bc/12183566/0b0be8b5af38/COPD-20-1995-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67bc/12183566/2c9c875e1e83/COPD-20-1995-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67bc/12183566/0b0be8b5af38/COPD-20-1995-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67bc/12183566/2c9c875e1e83/COPD-20-1995-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67bc/12183566/0b0be8b5af38/COPD-20-1995-g0002.jpg

相似文献

1
Withholding of Life-Sustaining Treatment and Mortality in ICU Patients with Severe Acute COPD Exacerbations: A Retrospective French Cohort.重症急性慢性阻塞性肺疾病加重期ICU患者生命维持治疗的 withhold 与死亡率:一项法国回顾性队列研究
Int J Chron Obstruct Pulmon Dis. 2025 Jun 18;20:1995-2009. doi: 10.2147/COPD.S502019. eCollection 2025.
2
Immunostimulants versus placebo for preventing exacerbations in adults with chronic bronchitis or chronic obstructive pulmonary disease.免疫刺激剂与安慰剂在预防慢性支气管炎或慢性阻塞性肺疾病成人恶化中的比较。
Cochrane Database Syst Rev. 2022 Nov 14;11(11):CD013343. doi: 10.1002/14651858.CD013343.pub2.
3
Magnesium sulfate for acute exacerbations of chronic obstructive pulmonary disease.硫酸镁治疗慢性阻塞性肺疾病急性加重。
Cochrane Database Syst Rev. 2022 May 26;5(5):CD013506. doi: 10.1002/14651858.CD013506.pub2.
4
Computer and mobile technology interventions for self-management in chronic obstructive pulmonary disease.用于慢性阻塞性肺疾病自我管理的计算机和移动技术干预措施。
Cochrane Database Syst Rev. 2017 May 23;5(5):CD011425. doi: 10.1002/14651858.CD011425.pub2.
5
Self-management interventions including action plans for exacerbations versus usual care in patients with chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者自我管理干预措施(包括针对病情加重的行动计划)与常规护理的比较。
Cochrane Database Syst Rev. 2017 Aug 4;8(8):CD011682. doi: 10.1002/14651858.CD011682.pub2.
6
Prophylactic antibiotics for adults with chronic obstructive pulmonary disease: a network meta-analysis.慢性阻塞性肺疾病成人患者的预防性抗生素治疗:一项网络荟萃分析。
Cochrane Database Syst Rev. 2021 Jan 15;1(1):CD013198. doi: 10.1002/14651858.CD013198.pub2.
7
Non-invasive ventilation for the management of acute hypercapnic respiratory failure due to exacerbation of chronic obstructive pulmonary disease.无创通气用于治疗慢性阻塞性肺疾病急性加重所致的急性高碳酸血症性呼吸衰竭。
Cochrane Database Syst Rev. 2017 Jul 13;7(7):CD004104. doi: 10.1002/14651858.CD004104.pub4.
8
Association of Patient-Reported Outcome Patterns and Major Clinical Factors with Frailty in Stable COPD.稳定期慢性阻塞性肺疾病患者报告结局模式及主要临床因素与衰弱的关联
Int J Chron Obstruct Pulmon Dis. 2025 Jun 12;20:1927-1937. doi: 10.2147/COPD.S517270. eCollection 2025.
9
Chronic non-invasive ventilation for chronic obstructive pulmonary disease.慢性阻塞性肺疾病的慢性无创通气。
Cochrane Database Syst Rev. 2021 Aug 9;8(8):CD002878. doi: 10.1002/14651858.CD002878.pub3.
10
Self-management interventions for people with chronic obstructive pulmonary disease.针对慢性阻塞性肺疾病患者的自我管理干预措施。
Cochrane Database Syst Rev. 2022 Jan 10;1(1):CD002990. doi: 10.1002/14651858.CD002990.pub4.

本文引用的文献

1
Respiratory Infection Triggering Severe Acute Exacerbations of Chronic Obstructive Pulmonary Disease.呼吸道感染引发慢性阻塞性肺疾病的严重急性加重。
Int J Chron Obstruct Pulmon Dis. 2024 Feb 27;19:555-565. doi: 10.2147/COPD.S447162. eCollection 2024.
2
COPD Exacerbation: Why It Is Important to Avoid ICU Admission.慢性阻塞性肺疾病急性加重:为何避免入住重症监护病房很重要。
J Clin Med. 2023 May 9;12(10):3369. doi: 10.3390/jcm12103369.
3
Management of Acute Exacerbations of Chronic Obstructive Pulmonary Disease in the ICU: An Observational Study From the OUTCOMEREA Database, 1997-2018.
慢性阻塞性肺疾病急性加重期在 ICU 中的管理:来自 OUTCOMEREA 数据库的观察性研究,1997-2018 年。
Crit Care Med. 2023 Jun 1;51(6):753-764. doi: 10.1097/CCM.0000000000005807. Epub 2023 Feb 15.
4
The Role of Palliative Care in COPD.慢性阻塞性肺疾病的姑息治疗作用。
Chest. 2022 May;161(5):1250-1262. doi: 10.1016/j.chest.2021.10.032. Epub 2021 Nov 3.
5
Non-invasive ventilation versus invasive weaning in critically ill adults: a systematic review and meta-analysis.无创通气与有创撤机在危重症成人中的比较:系统评价和荟萃分析。
Thorax. 2022 Aug;77(8):752-761. doi: 10.1136/thoraxjnl-2021-216993. Epub 2021 Oct 29.
6
Risk factors of unfavorable outcomes in chronic obstructive pulmonary disease patients treated with noninvasive ventilation for acute hypercapnic respiratory failure.无创通气治疗急性高碳酸血症呼吸衰竭的慢性阻塞性肺疾病患者不良结局的危险因素。
Clin Respir J. 2020 Nov;14(11):1083-1089. doi: 10.1111/crj.13245. Epub 2020 Aug 27.
7
Outcomes and Resource Utilization Among Patients Admitted to the Intensive Care Unit Following Acute Exacerbation of Chronic Obstructive Pulmonary Disease.慢性阻塞性肺疾病急性加重患者入住重症监护病房的结局和资源利用。
J Intensive Care Med. 2021 Sep;36(9):1091-1097. doi: 10.1177/0885066620944865. Epub 2020 Jul 28.
8
End-of-life practices in traumatic brain injury patients: Report of a questionnaire from the CENTER-TBI study.创伤性脑损伤患者的终末治疗实践:来自 CENTER-TBI 研究的问卷调查报告。
J Crit Care. 2020 Aug;58:78-88. doi: 10.1016/j.jcrc.2020.04.001. Epub 2020 Apr 21.
9
Characteristics and Outcomes of Critically Ill Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease in Australia and New Zealand.澳大利亚和新西兰慢性阻塞性肺疾病急性加重期危重症患者的特征和结局。
Ann Am Thorac Soc. 2020 Jun;17(6):736-745. doi: 10.1513/AnnalsATS.201911-821OC.
10
Early Do-Not-Resuscitate Directives Decrease Invasive Procedures and Health Care Expenses During the Final Hospitalization of Life of COPD Patients.早期不复苏指令可减少 COPD 患者生命终末期住院期间的侵入性操作和医疗费用。
J Pain Symptom Manage. 2019 Dec;58(6):968-976. doi: 10.1016/j.jpainsymman.2019.07.031. Epub 2019 Aug 9.